neuraxpharm Arzneimittel GmbH, PRASFARMA, S.L.
PolandAll drugs from this manufacturer
-
The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), especially in individuals for whom previous treatment has not been effective or in patients with a rapidly progressing, severe form of the disease. It helps to reduce the number of relapses and slow the progression of disability.
Dosage form: capsules, hard
Active substance Dosage fingolimod 0,50 mg fingolimod hydrochloride 0.56 mg ATC: L04AA27